✦ LIBER ✦

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

✍ Scribed by Sarah F. Adams; Evelyn B. Marsh; Wafic Elmasri; Steffanie Halberstadt; Stephanie VanDecker; Mary D. Sammel; Angela R. Bradbury; Mary Daly; Beth Karlan; Stephen C. Rubin

Book ID: 113963433
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 412 KB
Volume: 123
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.08.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA Mutation Status and Determinant of

BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin

✍ Safra, T.; Borgato, L.; Nicoletto, M. O.; Rolnitzky, L.; Pelles-Avraham, S.; Gev 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 385 KB